ARTELO BIOSCIENCES, INC. (ARTL) › Operating IncomeARTELO BIOSCIENCES, INC. (ARTL) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2014: -$15.3K2015: -$15.2K2016: -$29.7K2017: -$232.8K2018: -$2.34M2019: -$3.21M2020: -$4.69M2021: -$9.42M2022: -$10.29M2023: -$9.93M2024: -$10.11M2025: -$11.40M-$11.40M2014Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$11.40M-12.8%2024-$10.11M-1.8%2023-$9.93M+3.5%2022-$10.29M-9.2%2021-$9.42M-101.0%2020-$4.69M-46.0%2019-$3.21M-37.0%2018-$2.34M-906.7%2017-$232.8K-684.1%2016-$29.7K-94.8%2015-$15.2K+0.2%2014-$15.3K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share